4.6 Letter

Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Dermatology

Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient

F. Benhadou et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Letter Dermatology

Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs

A. Conti et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Letter Dermatology

SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor

R. Balestri et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)